BOLERO-3 Trial Commentary - 100351


BOLERO-3 Trial Commentary

Description: For more updates visit

Dr. Sunil Verma commenting on ASCO 2013 abstract #505: Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer
Shared By : oncologyeducation
Posted on : 06/23/13
Added : 5 years ago
Category : Breast Cancer

More From oncologyeducation

Nothing found.